-
All The Stocks That Moved From Monday's CNBC's 'Fast Money: Halftime Report'
Monday, April 4, 2022 - 1:25pm | 327CNBC’s ‘Fast Money: Halftime Report’ delivers market-moving news to investors. The commentary delivered by hosts of the show often moves the stocks mentioned. The information is collected and refined using Benzinga Pro’s News Tool. Benzinga Pro users can access this...
-
Analyst Sees Opportunity To Buy The Dip In Ulta Beauty, Adds To Conviction List
Friday, July 14, 2017 - 12:25pm | 395While Ulta Beauty Inc (NASDAQ: ULTA)'s stock has been tumbling amid Amazon.com, Inc. (NASDAQ: AMZN)'s fears, that did not stop Goldman Sachs analyst Matthew Fassler from upgrading Ulta to Buy with a $310 price target. He also added Ulta to Goldman’s Conviction List. “We are positive...
-
Harley Davidson's Registration Growth May Have Stalled; Goldman Downgrades Stock
Monday, June 6, 2016 - 9:07am | 284Goldman Sachs’ Patrick Archambault expects Harley-Davidson Inc (NYSE: HOG) to see a decline in U.S. registrations during 2Q16, which would mark the seventh successive quarter of year-on-year sales declines. Archambault downgraded the rating on the company from Buy to Neutral, while lowering...
-
Goldman Sachs Adds Royal Dutch Shell To 'Conviction Buy' List
Friday, March 11, 2016 - 10:01am | 283Goldman Sachs’ Henry Tarr reiterated a Buy rating on Royal Dutch Shell plc (ADR) (NYSE: RDS-A), while raising the price target from €23.50 to €27.50 and adding the stock to Goldman Sachs’ Conviction Buy List. Dividend Yield Tarr mentioned that the company had the highest...
-
Goldman Sachs Downgrades Marsh & McLennan To Neutral
Monday, June 22, 2015 - 7:37am | 54Analysts at Goldman Sachs downgraded Marsh & McLennan Companies, Inc. (NYSE: MMC) from Buy to Neutral. Marsh & McLennan shares have jumped 14.07 percent over the past 52 weeks, while the S&P 500 index has gained 7.51 percent in the same period. Marsh & McLennan shares closed at $59...
-
Goldman Sachs Sees Opportunity For Burger King To Take Market Share Away From McDonald's
Monday, December 8, 2014 - 2:09pm | 304Burger King Worldwide Inc (NYSE: BKW) growing U.S. same-store sales and its willingness to invest in international expansion suggest in can gain market share from competitors, an analyst said Monday. Goldman Sachs' Karen Holthouse resumed coverage of Burger King with a Buy rating and $39...
-
Goldman Sachs Says McDonald's Is Losing Ground
Monday, December 8, 2014 - 12:54pm | 351McDonald's Corporation (NYSE: MCD) is losing ground to competitors and its turnaround efforts may cause further short-term sales declines, an analyst said Monday. Goldman Sachs' Karen Holthouse resumed coverage on the fast-food giant Monday with a Neutral rating and $90 target. McDonald...
-
UPDATE: Goldman Sachs Downgrades American Express to Neutral on Limited Upside
Monday, January 14, 2013 - 12:59pm | 90Goldman Sachs downgraded American Express (NYSE: AXP) from Buy to Neutral and maintained a $65.00 price target. Goldman Sachs commented, "We downgrade AXP to Neutral from Buy; our price target remains $65. We see limited upside to out-year estimates (consensus of $4.75 in 2013E) without further...
-
UPDATE: Goldman Sachs Assumes Buy on Teradata on Sustainable EPS Growth
Friday, October 12, 2012 - 7:46am | 137Goldman Sachs assumed coverage on Teradata (NYSE: TDC) with a Buy rating. Goldman Sachs noted, "We believe Teradata can sustain high-teens EPS and FCF growth over the next several years as it gains share in the $11bn data warehousing market. We see the market moving in Teradata's direction as...
-
Retail Stocks Present Buying Opportunities: Goldman Sachs (GS)
Friday, December 4, 2009 - 3:14pm | 190Goldman Sach’s (NYSE: GS) sector overview of the retail sector highlights the impact on apparel sales in the U.S. owing to unseasonably warm weather. The Northeast region especially lagged in winter apparel sales. J.C. Penney (NYSE: JCP) and Kohl’s (NYSE: KSS) saw a slump in the children’s apparel...
-
Goldman Sach Upgrades Cardinal Health (CAH) to Buy from Neutral
Tuesday, September 15, 2009 - 9:49am | 25Goldman Sach upgraded Cardinal Health (NYSE: CAH)to Buy from Neutral due to relative valuation. The target price is $31 from $27.